UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma

Journal of clinical oncology, 1996-07, Vol.14 (7), p.2083-2090

1996

Volltextzugriff (PDF)

Variation in breast cancer surgery in Ontario

Canadian Medical Association journal, 1994-02, Vol.150 (3), p.345

1994

Volltextzugriff (PDF)

Extragonadal germ cell tumors. A 14‐year Toronto experience

Cancer, 1994-04, Vol.73 (7), p.1971-1979

1994

Volltextzugriff (PDF)

We may get this horse to water, but will it drink?

Canadian Medical Association journal (CMAJ), 1998-02, Vol.158 (3), p.345

Iscoe, N A

1998

Volltextzugriff (PDF)

Prostate cancer screening: waiting for Godot

Canadian Medical Association journal (CMAJ), 1998-12, Vol.159 (11), p.1375

Iscoe, N A

1998

Volltextzugriff (PDF)

Free-standing health care facilities: financial arrangements, quality assurance and a pilot study

Canadian Medical Association journal, 1998-02, Vol.158 (3), p.359

1998

Volltextzugriff (PDF)

The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma

British journal of surgery, 1985-08, Vol.72 (8), p.614-617

1985

Volltextzugriff (PDF)

A double-blind, randomized, prospective, phase II trial of capecitabine (Cap) plus enzastaurin (Enz) versus cap plus placebo in patients (pts) with advanced breast cancer (BrCa) and prior anthracycline and taxane treatment

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.1054-1054

2010

Volltextzugriff (PDF)

Observer error in the characterization of hepatic lesions in patients with neoplastic liver disease

Journal of clinical ultrasound, 1988-10, Vol.16 (8), p.577-579

1988

Volltextzugriff (PDF)

A phase II study of weekly edatreate (10-EDAM) in metastatic melanoma: a national cancer institute of Canada clinical trials groups study

Annals of oncology, 1993, Vol.4 (3), p.254-255

1993

Volltextzugriff (PDF)

Avelumab in unresectable/metastatic, progressive, grade 2–3 neuroendocrine neoplasms (NENs): Combined results from NET-001 and NET-002 trials

European journal of cancer (1990), 2022-07, Vol.169, p.74-81

2022

Volltextzugriff (PDF)

Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma

Cancer, 2006-04, Vol.106 (7), p.1431-1442

2006

Volltextzugriff (PDF)

Fat oxidation rate and the exercise intensity that elicits maximal fat oxidation decreases with pubertal status in young male subjects

Journal of applied physiology (1985), 2008-08, Vol.105 (2), p.742-748

2008

Volltextzugriff (PDF)

210 Electronic Health Record-Integrated Clinical Pathway and Transition to High Sensitivity Troponin to Promote Standardization of Attending Physician Chest Pain Care

Annals of emergency medicine, 2023-10, Vol.82 (4), p.S95-S96

2023

Volltextzugriff (PDF)

207 Evaluation of EHR-Integrated Clinical Pathway Implementation of High Sensitivity Troponin Upon Emergency Department Disposition Rates

Annals of emergency medicine, 2023-10, Vol.82 (4), p.S94

2023

Volltextzugriff (PDF)

The impact of staging by positron emission tomography (PET) on overall survival (OS) and progression-free survival (PFS) in the phase III PROCLAIM study

Annals of oncology, 2016-10, Vol.27, p.vi415-vi415

2016

Volltextzugriff (PDF)

Hypercapnia improves tissue oxygenation

Anesthesiology (Philadelphia), 2002-10, Vol.97 (4), p.801-806

2002

Volltextzugriff (PDF)

CO^sub 2^ rebreathing: an undergraduate laboratory to study the chemical control of breathing

Advances in physiology education, 2013-12, Vol.37 (4), p.361

2013

Volltextzugriff (PDF)

CO 2 rebreathing: an undergraduate laboratory to study the chemical control of breathing

Advances in physiology education, 2013-12, Vol.37 (4), p.361-369

2013

Volltextzugriff (PDF)

Randomsierte Phase-II-Doppelblindstudie: Enzastaurin versus Plazebo in Kombination mit Pemetrexed als Second-Line Therapie bei Patienten mit lokal fortgeschrittenem oder metastasiertem nichtkleinzelligem Bronchialkarzinom

Pneumologie (Stuttgart, Germany), 2010, Vol.64 (S 03)

2010

Volltextzugriff (PDF)

CO[subscript 2] Rebreathing: An Undergraduate Laboratory to Study the Chemical Control of Breathing

Advances in physiology education, 2013-12, Vol.37 (4), p.361-369

2013

Volltextzugriff (PDF)

Concurrent Pemetrexed/Cisplatin/Radiation for Unresectable Stage IIIA/B Non-Small Cell Lung Cancer: A Phase I/II Study

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S490-S490

2007

Volltextzugriff (PDF)

Differential detection of skeletal troponin I isoforms in serum of a patient with rhabdomyolysis: Markers of muscle injury?

Clinical chemistry (Baltimore, Md.), 2002-07, Vol.48 (7), p.1112-1114

2002

Volltextzugriff (PDF)

Cost analysis of secondary prophylaxis with oral clodronate versus pamidronate in metastatic breast cancer patients

Supportive care in cancer, 2004-12, Vol.12 (12), p.844-851

2004

Volltextzugriff (PDF)

A phase I study of concurrent pemetrexed (P)/cisplatin (C)/radiation (RT) for unresectable stage IIIA/B non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.7550-7550

2008

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma

Variation in breast cancer surgery in Ontario

Extragonadal germ cell tumors. A 14‐year Toronto experience

We may get this horse to water, but will it drink?

Prostate cancer screening: waiting for Godot

Free-standing health care facilities: financial arrangements, quality assurance and a pilot study

The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma

A double-blind, randomized, prospective, phase II trial of capecitabine (Cap) plus enzastaurin (Enz) versus cap plus placebo in patients (pts) with advanced breast cancer (BrCa) and prior anthracycline and taxane treatment

Observer error in the characterization of hepatic lesions in patients with neoplastic liver disease

A phase II study of weekly edatreate (10-EDAM) in metastatic melanoma: a national cancer institute of Canada clinical trials groups study

Avelumab in unresectable/metastatic, progressive, grade 2–3 neuroendocrine neoplasms (NENs): Combined results from NET-001 and NET-002 trials

Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma

Fat oxidation rate and the exercise intensity that elicits maximal fat oxidation decreases with pubertal status in young male subjects

210 Electronic Health Record-Integrated Clinical Pathway and Transition to High Sensitivity Troponin to Promote Standardization of Attending Physician Chest Pain Care

207 Evaluation of EHR-Integrated Clinical Pathway Implementation of High Sensitivity Troponin Upon Emergency Department Disposition Rates

The impact of staging by positron emission tomography (PET) on overall survival (OS) and progression-free survival (PFS) in the phase III PROCLAIM study

Hypercapnia improves tissue oxygenation

CO^sub 2^ rebreathing: an undergraduate laboratory to study the chemical control of breathing

CO 2 rebreathing: an undergraduate laboratory to study the chemical control of breathing

Randomsierte Phase-II-Doppelblindstudie: Enzastaurin versus Plazebo in Kombination mit Pemetrexed als Second-Line Therapie bei Patienten mit lokal fortgeschrittenem oder metastasiertem nichtkleinzelligem Bronchialkarzinom

CO[subscript 2] Rebreathing: An Undergraduate Laboratory to Study the Chemical Control of Breathing

Concurrent Pemetrexed/Cisplatin/Radiation for Unresectable Stage IIIA/B Non-Small Cell Lung Cancer: A Phase I/II Study

Differential detection of skeletal troponin I isoforms in serum of a patient with rhabdomyolysis: Markers of muscle injury?

Cost analysis of secondary prophylaxis with oral clodronate versus pamidronate in metastatic breast cancer patients

A phase I study of concurrent pemetrexed (P)/cisplatin (C)/radiation (RT) for unresectable stage IIIA/B non-small cell lung cancer (NSCLC)

Aktive Filter

Suchergebnisse filtern